The compound has been investigated while in the patent literature for its anxiolytic Attributes and decreased sedative, hypnotic, and ataxic facet-effects, but it doesn't appear to be accredited for clinical use. ?ukasik-G?ebocka et alPyrazolam is usually a triazolo-BZD with evidently little data, structurally similar to alprazolam but is brominate